Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Geron Corp GERN

Alternate Symbol(s):  GERNW

Healthcare Biotechnology
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the... see more

Recent & Breaking News (NDAQ:GERN)

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SSL, GERN and ALGN

ACCESSWIRE IA March 5, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Geron Corporation (GERN) Investors Who Suffered Losses to Contact its Attorneys: Application Deadline Approaching

ACCESSWIRE IA March 4, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, GERN and BYND

ACCESSWIRE IA March 4, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm

GlobeNewswire March 4, 2020

SHAREHOLDER ALERT: PTLA GERN AAN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 4, 2020

Geron Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm

Newsfile March 4, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of QD, GERN and CCI

ACCESSWIRE IA March 3, 2020

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline - GERN

GlobeNewswire March 3, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GERN, LK and HPQ

ACCESSWIRE IA March 3, 2020

QD & GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines

ACCESSWIRE IA March 3, 2020

SHAREHOLDER ALERT: GERN HPQ AAN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 2, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Geron Corporation (GERN) Investors Who Suffered Losses to Contact its Attorneys: Application Deadline in Three Weeks

GlobeNewswire March 2, 2020

CLASS ACTION UPDATE for OPRA, GERN and CCI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA March 2, 2020

SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 2, 2020

SHAREHOLDER ALERT: GERN WBK JELD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 1, 2020

FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 29, 2020

CLASS ACTION UPDATE for GERN, HPQ and BDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA February 28, 2020

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 28, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SSL, GERN and HPQ

ACCESSWIRE IA February 28, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Geron Corporation (GERN) Investors Who Suffered Losses to Contact its Attorneys: Application Deadline Approaching

ACCESSWIRE IA February 27, 2020